In this regard, electrophilic dimethyl fumarate (DMF) has shown therapeutic potential in PD and displays a multi-target mechanism of action beyond Nrf2 signaling, in the course of targeting the redox-sensitive-cysteine proteome11,12,14,43. Here, NFE2L2 is linked to Parkinson disease.